Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

LENZ Therapeutics Q3 2026: Cash and Marketable Securities

LENZ Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 3, 2026, covering the fiscal quarter ended September 30, 2026.

Anjali Anand | 03 November 2026

Expro Ltd Posts Net Loss in Q3 2026 Amid Merger Costs

Expro Ltd filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 3, 2026, reporting a net loss for the third quarter and elevated merger and integration expense.

Aditi Sarkar | 03 November 2026

AES Corp Q3 2026: 713.6M Shares, Ohio Rate Order

The AES Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 3, 2026, disclosing share count, subsidiary structure changes, and regulatory developments including an authorized annual rate increase for AES Ohio.

Aditi Sarkar | 03 November 2026

Mercury General Q3 2026: Net Loss of $13.7M on Investment Losses

Mercury General Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 3, 2026, reporting a net loss of $13,685 thousand for the third quarter alongside nine-month net income of $440,237 thousand.

Shwetambri Chauhan | 03 November 2026

Tarsus Pharmaceuticals Q3 2026 10-Q: XDEMVY Sales and Pipeline

Tarsus Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 3, 2026, disclosing financial and operational details for the third quarter of fiscal 2026.

Aditi Sarkar | 03 November 2026

Corebridge Financial Q3 2026 10-Q: 438M Shares Outstanding

Corebridge Financial, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the Securities and Exchange Commission on November 3, 2026, disclosing financial statements and related information for the third quarter of 2026.

Anjali Anand | 03 November 2026

Mercury General Q3 2026 Earnings Results Announced

Mercury General Corporation filed a Form 8-K with the SEC on November 3, 2026, announcing the release of its financial results for the third quarter ended September 30, 2026.

Vinay Lochav | 03 November 2026

Avery Dennison Q3 2026: Cash Rises to $271.4M

Avery Dennison Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 3, 2026, covering the company's fiscal third quarter financial results.

Shwetambri Chauhan | 03 November 2026

Corcept Q3 2026: Revenue Hits $340.5M, Net Income Surges

Corcept Therapeutics Incorporated filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 3, 2026, reporting third-quarter net product revenue of $340,472 thousand and net income of $126,778 thousand.

Anjali Anand | 03 November 2026

Huron Consulting Q3 2026: Revenue Rises to $491.5M

Huron Consulting Group Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing third-quarter and nine-month financial results including revenue growth, net income, and balance sheet changes.

Shwetambri Chauhan | 03 November 2026
Support

Hi! How can we help you today?

Loading…